Compared with healthy subjects, NAFLD patients have higher levels of ROS and lipid peroxidation products, lower levels of antioxidant enzymes [e.g. SOD and catalase (CAT)], and decreased levels of antioxidant compounds (e.g. GSH). This evidence concerns the gene CAT and metabolic dysfunction-associated steatotic liver disease.